Acetylcholinesterase and HHV-8 in squamous cell carcinoma and retinoblastoma

In Vivo

Volumn 23, Issue 5, 2009, Pages 679-683

  Qavi, Hamida ^a   Al Rajhi, Ali A ^b  

^a UNIVERSITY OF HOUSTON   (United States)

^b KING KHALED EYE SPECIALIST HOSPITAL   (Saudi Arabia)

Author keywords

AChe; HHV 8; Retinoblastoma; SCC

Indexed keywords

ACETYLCHOLINESTERASE; VIRUS ANTIGEN;

ANTIGEN DETECTION; ARTICLE; ENZYME ANALYSIS; HUMAN; HUMAN HERPESVIRUS 8; HUMAN TISSUE; RETINOBLASTOMA; SQUAMOUS CELL CARCINOMA; TISSUE SECTION; VIRUS CARCINOGENESIS;

EID: 70350053097     PISSN: 0258851X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. Taylor P: The cholinesterase. J Biol Chem 266: 4025-4028, 1991.
2. Roberts WL, Doctor BP, Foster JD and Rosenberry TL: Bovine brain acetylcholinesterase primary sequences involved in intersubunit disulfide linkage. J Biol Chem 266: 7481-7487, 1991.
3. Zakut H, Ehrlich G, Ayalon A, Prody CA, Malinger G, Seidman S, Ginzberg D, Kehlenbach R and Soreq H: Acetylcholinesterase and butylcholinesterase gene co-amplify in primary ovarian carcinoma. J Clin Invest 86: 900-908, 1990.
4. Lapidot-Lifson Y, Prody CA, Ginzberg D, Meytes D, Zakut H and Soreq H: Co-amplification of human acetylcholinesterase and butylcholinesterase genes in blood cells; correlation with various leukemias and abnormal megakaryocytopoiesis. Proc Natl Acad Sei USA 86: 4715-4717, 1989.
5. Malinger G, Zakut H and Soreq H: Cholinoceptive properties of human primordial, preantial and antral ocytes in situ hybridization and biochemical evidence for expression of Cholinesterase genes. J Mol Neuro Sci 1: 77-84, 1991.
6. Soreq H, Lapidot Lifson Y and Zakut H: A role for cholinesterase in tumorogenesis. Cancer Cells 3: 511-516, 1991.
7. Seidman S, Sternfeld M, Ben Aziz-Aloya R, Timberg R, Kaufer-Nachun D and Soreq H: Synaptic and epidermal accumulations of human acetylcholinesterase are encoded by alternative 3-terminal axons. Mol Cell Biol 15: 2993-3002, 1995.
8. Karpel R, Aloya R, Sternfeld M, Ehrlich G, Ginzberg D, Torroni P, Clemente F, Zakut H and Soreq H: Expression of three alternative acetylcholinesterase messenger RNAs in human tumor cell lines of different tissue origins. Exp Cell Res 210: 268-277, 1994.
9. Onganer P, Mustafa BA, Djamgoz M, Whyte K and Greenfield S: An acetylcholinesterase-derived peptide inhibits endocytic membrane activity in a human metastatic breast cancer cell line. Biochim Biophys Acta 1760: 415-420, 2006.
10. Battisti V, Schetinger MR, Maders LD, Santos KF, Bagatini MD, Correa MC, Spanevello RM, do Carmo Araújo M and Morsch VM: Changes in acetylcholinesterase (AChE) activity in lymphocytes and whole blood in acute lymphoblastic leukemia patients. Clin Chim Acta 402 (1-2): 114-118, 2009.
11. Martínez-López de Castro A, Nieto-Cerón S, Aurelio PC, Galbis-Martínez L, Latour-Pérez J, Torres-Lanzas J, Tovar-Zapata I, Martínez-Hernández P, Rodríguez- López JN and Cabezas-Herrera J: Cancer-associated differences in acetlycholinesterase activity in bronchial aspirates from patients with lung cancer. Clin Sci (Lond) 115(8): 245-253, 2008.
12. Barbosa M, Rios O, Velasquez M, Villalobos J and Ehrmanns J: Acetylcholinesterase and butylcholinesterase histochemical activities and tumor cell growth in several brain tumors. Surgical Neurology 55: 106-112, 2001. (Pubitemid 32297687)
13. Perry C, Sklan EH, Birikh K, Shapira M, Trejo L, Eldor A and Soreq H: Complex regulation of acetylcholinesterase gene expression in human brain tumors. Oncogene 21: 8421-8441, 2002. (Pubitemid 36054884)
14. 2+ response in a subclone of PC-12 cells by single cell flow cytomentry. Inhibition of response by bradykinin. J Biol Chem 266: 11738-11745, 1991.
15. Zhang XJ, Yang L, Zhao O, Coen JP, He HY, Jin QH, Guo LH, Almany M, Zhang LY and Shi YF: Induction of acetylcholinesterase expression during apoptosis in various cell types. Cell Death Diff 9: 790-800, 2002.
16. Santos SC, Vala I, Miguel C, Barata JI, Garcao P, Aqostinho P, Mendes M, Coelho AV, Calado A, Oliveira CR, Silva JM and Saldanha C: Expression and subcellular localization of a novel nuclear acetylcholinesterase protein. J Biol Chem 282(35): 25597-25603, 2007. (Pubitemid 47372784)
17. Musthafa CP, Moosa A, Chandrashekharan AP, Nando Kumar R, Narayanan AV and Balakrishnan V: Intestinal pseudo-obstruction as initial presentation of thymoma. Indian J Gastroenterol 25(5): 264-265, 2006. (Pubitemid 46708862)
18. Kaur H and Bigbee IW: Neuronal and glial cell biology. J Neurochem 81: 16-21, 2002.
19. Johnson G and Moore SW: Association of the HNK-1 epitope with the detergent soluble G4 isoform of acetylcholinesterase from human neuroblastoma cells. Int J Dev Neur Sci 19: 439-445, 2001. (Pubitemid 32500339)
20. Brasnu E, Wechsler B, Bron A, Charlotte F, Bliefeld P, Lehoang P, Marcelin AG and Bodaghi B: Efficacy of interferon-alpha for the treatment of Kaposi's sarcoma herpesvirus-associated uveitis. Am J Ophthalmol 140(4): 746-748, 2005. (Pubitemid 41455329)
21. Ablashi DV, Chatlynne LG, Whitman JE and Cesarman E: Spectrum of Kaposi's sarcoma-associated herpesvirus or human herpesvirus 8 diseases. Clin Microbiol Rev 15: 439-464, 2002. (Pubitemid 34761352)
22. Qavi HB: The Human Herpesvirus 8 and Kaposis Sarcoma: Duance's Foundation of Clinical Ophthalmology. Tasman W and Jaeger E (eds.). J. B. Lippincott Company, USA 93A: 1-10, 2003.
23. Güvenç MG, Midilli K, Ozdoǧan A, Inci E, Tahamiler R, Enver O, Sirin G, Ergin S, Kujkucu M, Divanoglu EO, Yilmaz G and Altas K: Detection of HHV-8 and HPV in laryngeal carcinoma. Auris Nasus Larynx 35(3): 357-362, 2008. (Pubitemid 352010484)
24. Verma V, Shen D, Sieving PC and Chan CC: The role of infectious agents in the etiology of ocular adnexal neoplasia. Surv Ophthalmol 53(4): 312-331, 2008. (Pubitemid 351842561)
25. Inaqi R, Kosuqe H, Nishimoto S, Yashikawa K and Yamamishi K: Kaposi's sarcoma-associated herpesvirus (KSHV) sequences in premalignant and malignant skin tumors. Arch Virol 141: 2217-2223, 1996. (Pubitemid 27012282)
26. Rady PL, Yen A, Rollefson JL, Orango I, Bruce S, Hughes TK and Tyring SK: Herpesvirus-like DNA sequences in non-kaposi's sarcoma skin lesions of transplant patients. Lancet 345: 1339-1340, 1995.
27. Verma SC, Lan K and Robertson E: Structure and function of latency-associated nuclear antigen. Curr Top Microbiol Immunol 312: 101-136, 2007. (Pubitemid 47400345)
28. Qavi HB, Green MT, Lewis DE, Hollinger FB, Pearson G and Ablashi DV: HIV-1 and HHV-6 antigens and transcripts in retinal cells from AIDS patients in the absence of CMV infection. Inves Ophthal Vis Sci 36: 2040-2047, 1995.
29. Bortek J, Bartkova J and Lukas A: The retinoblastoma protein pathway in cell cycle control and cancer. Exp Cell Res 237: 1-6, 1997. (Pubitemid 27528021)
30. Levine AJ: P53, the cellular gatekeeper for growth and division. Cell 88: 323-331, 1997.
31. Harbour JW: Eye cancer: Unique insight into oncogenesis, the Cogan Lecture. IOVS 47: 1737-1745, 2006.
32. Beniston RG, Morgan IM and O'Brian V: E7 and P53 in papilloma virus oncogenesis cell transformation. Carcinogenesis 22: 1069-1076, 2001. (Pubitemid 32633606)
33. Dyson N, Howley PM, Munger K and Harlow E: The human papilloma virus-16, E7 oncoprotein is able to bind to the retinoblastoma gene product. Science 243: 934-947, 1989.
34. Molho-Pessach V and Lotem M: Viral carcinogenesis in skin cancer. Curr Probl Dermatol 35: 39-51, 2007.
35. Underbrink MP, Hoskins SL, Pou AM and Albrecht T: Viral interaction: a possible contributing factor in head and neck cancer progression. Acta Otolaryngol 128(12): 1361-1369, 2008.
36. Grigoli G, Prikhod K and Yan W: Baculovirus P33 binds human P53 and enhances P53-mediated apoptosis. J Viral 73(2): 1227-1234, 1999.
37. Perry CA, Sklan EH and Soreq H: CREB regulates AChE-R-induced proliferation of human glioblastoma cells. Neoplasia 6: 279-286, 2004. (Pubitemid 38657084)
38. Garcia-Allyson MS, Saez-Valero J, Munoz-Delgado E and Vidal CJ: Identification of hybrid cholinesterase forms consisting of acetyl- and butylcholinesterase subunits in human glioma. Neuroscience 107: 100-208, 2001.
39. Johnson G and Moore SW: Localization of a novel adhesion-promoting site on acetylcholinesterase using catalytic antiacetylcholinesterase antibodies displaying cholinersterase-like activity. Appl Biochem Biotechnol 83: 131-144, 2000.
40. Mack A and Robitzki A: The key role of butyrylcholinesterase during neurogenesis and neural disorders: an antisense-5 butyrylcholinesterase-DNA study. Prog Neurobiol 60: 607-628, 2000. (Pubitemid 30100400)
41. Wasserman LM, Newsham I, Huang HJ and Cavenee WK: cAMP effect on myogenic gene expression in rhabdomyosarcoma cells. Exp Cells Res 25: 55-62, 1996. (Pubitemid 26293415)
42. Kamal MA, Nasim FH and al-Jafari AA: Investigation of the effect of anti-neoplastic drugs, cyclophosphamide, cisplatin and methotrexate on the turnover kinetics of human erythrocyte acetylcholinesterase. Biochem Mol Biol Int 39: 293-302, 1996.
43. McQueen MJ: Clinical and analytical considerations in the utilization of cholinesterase measurements. Clin Chem Acta 7: 91-105, 1995.
44. Soreq H and Zakut H: Amplification of butyrylcholinesterase and acetylcholinesterase genes in normal and tumor tissues: putative relationship to organophosphorous poisoning. Pharm Res 7: 1-7, 1990.